#mabs
Discover how a rapid CIU assay predicts agonism in hIgG2 mAb variants by analyzing gas-phase unfolding and hinge-engineering, revolutionizing antibody design. PMID:42373639, Nat Commun 2026, @NatureComms https://doi.org/10.1038/s41467-026-75137-y #Medsky #Pharmsky #RNA #ASHG #ESHG 🧪
Gas-phase unfolding assay rapidly predicts structure-function relationships in engineered antibodies with tuned flexibilities | Nature Communications
Human (h)IgG2 monoclonal antibodies (mAbs) are potent agonists due, in part, to their ability to undergo disulfide shuffling within their hinge regions. Herein, we describe a rapid, sensitive, collision-induced unfolding (CIU) assay that possesses a predictive relationship between gas-phase protein unfolding and agonism in hIgG2 variants. Furthermore, our results highlight the significance of hinge engineering in tuning mAb structure-function relationships for the development of future biotherapeutics. The agonistic activity of IgG2 antibodies depends, in part, on the flexibility of their hinge region, which is slow to measure in full-length antibodies. Here, the authors develop a rapid mass spectrometry assay that gauges this flexibility and predicts the agonism of engineered antibody variants.
doi.org
September 29, 2026 at 9:00 AM
September 28, 2026 at 6:53 PM
Antibody Therapeutics (IF=4.8, Oxford University Press) ⚡ Research Highlight - ACE2-Fc and DPP4-Fc decoy receptors against SARS-CoV-2 and MERS-CoV variants: a quick therapeutic option for current and future coronaviruses outbreaks.
doi.org/10.1093/abt/...
#immunoadhesins #mabs
September 28, 2026 at 1:44 PM
Rumor has it, "MILF" actually stands for "mAb I'd Like to Fluoresce." Huge, if true!

Always true? We really do ❤️ older mAbs!

#AntibodiesForResearch #ShowYourWork #SeenWithDSHB #MWSDB26
September 26, 2026 at 10:01 PM
Doctor: Mr mabs you have just under 3 hours to live

Me:
September 26, 2026 at 2:22 PM
Don't forget to tag your category!

#Figure1 — an image a paper could hang on

#OopsArt — a beautiful outtake that didn't make the manuscript—please tell us why!

#WeLuvOldermAbs ("We ❤️ Older mAbs") — any image made with a cell line/antibody older than the person who did the imaging
September 26, 2026 at 12:31 AM
Shut up Mabs! Lol
September 25, 2026 at 5:27 PM
Morn, Mabs :3 I hope so too, me love! Thank you 🥺🫂
September 23, 2026 at 6:33 AM
the mabs community knows this is an agenda i FULLY support
TK better have Deonna drop the Pure title to Emi
September 22, 2026 at 6:32 PM
Neurologic mAbs are delivering clinical benefit across MS, NMOSD and early Alzheimer’s disease. As efficacy converges, operational execution and safety governance are emerging as key differentiators.

Read more. https://ow.ly/vi7M50ZQ7p7
September 22, 2026 at 2:30 PM
HOLD FAST, Mabs! You are not alone.

This Election Day will be a dramatic turning point, as long as we VOTE and GET OUT THE VOTE.

Better days ahead...
September 21, 2026 at 5:50 PM
📈 Mitochondrial membrane potential-enriched CHO host: a novel and powerful tool for improving biomanufacturing capability.
mAbs(2022)
#Biotechnology #Science
https://pubmed.ncbi.nlm.nih.gov/35030984/
pubmed.ncbi.nlm.nih.gov
September 21, 2026 at 2:58 AM
I usually do Mabs but I'm going with this one this year! I'm not going to force it and I'm not going to draw every day. Join us!!
🎃🎨 #hARToween26 Prompt List for anyone who wants to peruse it &/or start early. Will repost it on the 25th & 30th.

We start Oct 1

Anyone is welcome to draw using all or any of the prompts, w one rule: *ABSOLUTELY NO AI*

Use the hashtag for your art to pop up in the feed (link is in comments)
September 21, 2026 at 1:34 AM
What do you think would be the best MABs to use if not Teclistamab and Daratumumab?

PLEX and IVIG are difficult to access monthly on a long term basis for many people including me.

It almost seems we haven’t moved from these basic treatments for decades now with nothing new. Anything?
September 19, 2026 at 4:28 AM
Unfortunately, most of the antibodies used in the PJ.2.1 Yunlong Cao study weren't used in prior studies, where LF.7 vs LF.7.2 or LF.7 vs LF.7.9 were compared, which clearly showed the effect of A475V. And since the epitopes of the mAbs listed aren't described, no way to know how A475V affects them.
September 18, 2026 at 11:12 PM
#pinball #retrogames #retrogaming #PastTimesArcade Music Man (Williams, 1960) Designed by Harry Mabs, art by George Molentin. This four flipper EM features a disappearing jet bumper. Located at Past Times Arcade, Girard, OH.
September 18, 2026 at 2:42 AM
🔍 Spotted in Liver International!
Researchers from Mie University used our [BA-F8] and [SC-71] mAbs in a study showing that elevated conjugated bile acids drive inflammation, muscle loss, and fiber-type shifts in CLD
📄 https://dshb.biology.uiowa.edu/BA-F8
🧫 https://dshb.biology.uiowa.edu/SC-71
September 16, 2026 at 9:00 PM
Timely revisit! Abs power MMR efficacy against measles

Measles-specific mAbs isolated from MMR vaccinee potently & broadly neutralize, target conserved sites & protect animals post exposure, opening means to prevent/treat measles as outbreaks re-emerge
www.cell.com/cell-host-mi...
Human neutralizing antibodies targeting the measles virus hemagglutinin and fusion surface proteins
Acciani, Zyla et al. identify a panel of human monoclonal antibodies against measles virus surface proteins. These antibodies neutralize with picomolar potency, target conserved sites, broadly neutral...
www.cell.com
September 16, 2026 at 5:11 PM
Forces him to do it via her usual shenanigans. She might even provide him with the material to summon some Celtic hero due to Mabs lineage. 2. Harry learns about it through being chosen and is really reluctant about but learning that Cowl has been chosen as well decides he must win it to prevent
September 16, 2026 at 3:51 PM
Use of mAbs also impressive 95+% reduction in hospitalisation of infants, BUT some evidence that esp subtype B RSV is accumulating mutations leading to resistance to neutralisation.
September 16, 2026 at 7:13 AM
🔍Spotted in Physiological Reposts!
Mayo Clinic researchers used our BA-F8 and SC-71 mAbs in a study linking tibialis anterior muscle atrophy with large lumbar motor neuron loss in old rats.
📄 https://tinyurl.com/3xj9thp3
🧫 https://dshb.biology.uiowa.edu/BA-F8
🧫 https://dshb.biology.uiowa.edu/SC-71
September 15, 2026 at 9:00 PM
🤖 Impact of process parameters on IgG glycosylation in CHO systems: a comprehensive quantitative analysis.
mAbs(2026)
#Biotechnology #Science
https://pubmed.ncbi.nlm.nih.gov/41833362/
pubmed.ncbi.nlm.nih.gov
September 15, 2026 at 8:48 PM
The situation is less clear for PJ.2.1. Compared to other circulating variants, it is more susceptible to class 3 and class 5 antibodies. These tend to be Omicron-specific, but I cannot find the exact epitopes of the mAbs highlighted in magenta below, so I can't make any precise predictions.
September 15, 2026 at 10:32 AM